|
US4288627A
(en)
|
1980-02-12 |
1981-09-08 |
Phillips Petroleum Company |
Oxidation of thiols employing cobalt molybdate/triethylamine catalyst
|
|
NZ202757A
(en)
|
1981-12-23 |
1985-11-08 |
Novo Industri As |
Peptides and medicaments
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
|
JP3262329B2
(ja)
|
1990-01-24 |
2002-03-04 |
アイ． バックレイ，ダグラス |
糖尿病治療に有用なｇｌｐ―１アナログ
|
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
|
DK0531372T4
(da)
|
1990-05-09 |
2004-08-09 |
Novozymes As |
Cellulasepræparat omfattende et endoglucanaseenzym
|
|
DK36392D0
(da)
|
1992-03-19 |
1992-03-19 |
Novo Nordisk As |
Anvendelse af kemisk forbindelse
|
|
US5846747A
(en)
|
1992-03-25 |
1998-12-08 |
Novo Nordisk A/S |
Method for detecting glucagon-like peptide-1 antagonists and agonists
|
|
DK39892D0
(da)
|
1992-03-25 |
1992-03-25 |
Bernard Thorens |
Peptid
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
WO1995005848A1
(en)
|
1993-08-24 |
1995-03-02 |
Novo Nordisk A/S |
Protracted glp-1
|
|
CA2171207C
(en)
|
1993-09-07 |
2010-03-30 |
Orville G. Kolterman |
Methods for regulating gastrointestinal motility
|
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
US5523449A
(en)
|
1995-05-17 |
1996-06-04 |
Bayer Corporation |
Process for preparing phosphorodichlorido-dithioates by reacting alkylmercaptans with phosphorus trichloride in the presence of sulfur
|
|
JP2000516912A
(ja)
|
1996-06-05 |
2000-12-19 |
ロシュ ダイアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング |
エキセンジン類似体、それらの製造方法およびそれらを含有する製剤
|
|
US6110703A
(en)
|
1996-07-05 |
2000-08-29 |
Novo Nordisk A/S |
Method for the production of polypeptides
|
|
PT966297E
(pt)
|
1996-08-08 |
2009-03-18 |
Amylin Pharmaceuticals Inc |
Regulação da motilidade gastrintestinal
|
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6277819B1
(en)
|
1996-08-30 |
2001-08-21 |
Eli Lilly And Company |
Use of GLP-1 or analogs in treatment of myocardial infarction
|
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
BRPI9711437B8
(pt)
|
1996-08-30 |
2021-05-25 |
Novo Nordisk As |
derivados de glp-1
|
|
US6006753A
(en)
|
1996-08-30 |
1999-12-28 |
Eli Lilly And Company |
Use of GLP-1 or analogs to abolish catabolic changes after surgery
|
|
ES2239364T3
(es)
|
1996-09-09 |
2005-09-16 |
Zealand Pharma A/S |
Sintesis de peptidos en fase solida.
|
|
CA2265454A1
(en)
|
1996-09-09 |
1998-03-19 |
Zealand Pharmaceuticals A/S |
Peptide prodrugs containing an alpha-hydroxyacid linker
|
|
UA65549C2
(uk)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
|
WO1998022577A1
(en)
|
1996-11-15 |
1998-05-28 |
Maria Grazia Masucci |
Fusion proteins having increased half-lives
|
|
EP0996459B1
(en)
|
1997-01-07 |
2005-09-21 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the reduction of food intake
|
|
US6410511B2
(en)
|
1997-01-08 |
2002-06-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
|
US6136784A
(en)
|
1997-01-08 |
2000-10-24 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist pharmaceutical compositions containing insulin
|
|
AU5850798A
(en)
|
1997-02-05 |
1998-08-26 |
1149336 Ontario Inc. |
Polynucleotides encoding proexendin, and methods and uses thereof
|
|
US5846937A
(en)
|
1997-03-03 |
1998-12-08 |
1149336 Ontario Inc. |
Method of using exendin and GLP-1 to affect the central nervous system
|
|
TR199903120T2
(xx)
|
1997-05-07 |
2000-05-22 |
Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften |
Yeni sistein türevleri, bunların üretimi için işlemler ve bunları ihtiva eden farmasötik maddeler.
|
|
US7157555B1
(en)
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
|
NZ502592A
(en)
|
1997-08-08 |
2002-03-28 |
Amylin Pharmaceuticals Inc |
Exendin agonist peptides and their use in the treatment of type I and II diabetes
|
|
CA2310097C
(en)
|
1997-11-14 |
2014-07-29 |
Amylin Pharmaceuticals, Inc. |
Novel exendin agonist compounds
|
|
US7223725B1
(en)
|
1997-11-14 |
2007-05-29 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
|
BR9814189A
(pt)
|
1997-11-14 |
2000-10-03 |
Amylin Pharmaceuticals Inc |
"compostos agonistas da exendina"
|
|
US7220721B1
(en)
|
1997-11-14 |
2007-05-22 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist peptides
|
|
WO1999029336A1
(en)
|
1997-12-05 |
1999-06-17 |
Eli Lilly And Company |
Glp-1 formulations
|
|
US6703359B1
(en)
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
|
CA2320371C
(en)
|
1998-02-13 |
2012-01-17 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and glp-1
|
|
EP1062240B1
(en)
|
1998-02-27 |
2010-04-28 |
Novo Nordisk A/S |
N-terminally modified glp-1 derivatives
|
|
EP1056775B1
(en)
|
1998-02-27 |
2010-04-28 |
Novo Nordisk A/S |
Glp-1 derivatives of glp-1 and exendin with protracted profile of action
|
|
IL138214A0
(en)
|
1998-03-09 |
2001-10-31 |
Zealand Pharmaceuticals As |
Pharmacolgically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
|
|
DE69918070T2
(de)
|
1998-03-13 |
2005-08-25 |
Novo Nordisk A/S |
Stabilisierte, wässrige Glukagonlösungen, enthaltend Detergenzien
|
|
WO1999049788A1
(en)
|
1998-03-30 |
1999-10-07 |
Focus Surgery, Inc. |
Ablation system
|
|
SE9802080D0
(sv)
|
1998-06-11 |
1998-06-11 |
Hellstroem |
Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
|
|
JP4624558B2
(ja)
|
1998-08-10 |
2011-02-02 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ， アズ レプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
ＧＬＰ−１またはＥｘｅｎｄｉｎ−４による、非インスリン産生細胞のインスリン産生細胞への分化、およびその使用
|
|
DE69926007T2
(de)
|
1998-10-07 |
2005-12-29 |
Medical College Of Georgia Research Institute, Inc. |
Glukose-abhängiges, insulinotropisches peptid für die verwendung als osteotropes hormon
|
|
US6284725B1
(en)
|
1998-10-08 |
2001-09-04 |
Bionebraska, Inc. |
Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
|
|
US6903186B1
(en)
|
1998-12-07 |
2005-06-07 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S |
Analogues of GLP-1
|
|
DE60044041D1
(de)
|
1999-01-14 |
2010-04-29 |
Amylin Pharmaceuticals Inc |
Exendine zur Glucagon Suppression
|
|
US7399489B2
(en)
|
1999-01-14 |
2008-07-15 |
Amylin Pharmaceuticals, Inc. |
Exendin analog formulations
|
|
AU777564B2
(en)
|
1999-01-14 |
2004-10-21 |
Amylin Pharmaceuticals, Inc. |
Novel exendin agonist formulations and methods of administration thereof
|
|
US6451987B1
(en)
|
1999-03-15 |
2002-09-17 |
Novo Nordisk A/S |
Ion exchange chromatography of proteins and peptides
|
|
CZ20013018A3
(cs)
|
1999-03-17 |
2002-02-13 |
Novo Nordisk A/S |
Způsob pro acylování aminoskupiny peptidu nebo proteinu a sloučenina
|
|
US6451974B1
(en)
|
1999-03-17 |
2002-09-17 |
Novo Nordisk A/S |
Method of acylating peptides and novel acylating agents
|
|
US6271241B1
(en)
|
1999-04-02 |
2001-08-07 |
Neurogen Corporation |
Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors
|
|
WO2000066629A1
(en)
|
1999-04-30 |
2000-11-09 |
Amylin Pharmaceuticals, Inc. |
Modified exendins and exendin agonists
|
|
US6924264B1
(en)
|
1999-04-30 |
2005-08-02 |
Amylin Pharmaceuticals, Inc. |
Modified exendins and exendin agonists
|
|
PT1180121E
(pt)
|
1999-05-17 |
2004-03-31 |
Conjuchem Inc |
Peptidos insulinotropicos de longa duracao
|
|
US7601691B2
(en)
|
1999-05-17 |
2009-10-13 |
Conjuchem Biotechnologies Inc. |
Anti-obesity agents
|
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
|
US6344180B1
(en)
|
1999-06-15 |
2002-02-05 |
Bionebraska, Inc. |
GLP-1 as a diagnostic test to determine β-cell function and the presence of the condition of IGT and type II diabetes
|
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
|
US6528486B1
(en)
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
|
US6586438B2
(en)
|
1999-11-03 |
2003-07-01 |
Bristol-Myers Squibb Co. |
Antidiabetic formulation and method
|
|
WO2002034285A2
(en)
|
2000-10-20 |
2002-05-02 |
Coolidge Thomas R |
Treatment of hibernating myocardium and diabetic cardiomyopathy with a glp-1 peptide
|
|
GB0121709D0
(en)
|
2001-09-07 |
2001-10-31 |
Imp College Innovations Ltd |
Food inhibition agent
|
|
WO2003053460A1
(en)
|
2001-12-19 |
2003-07-03 |
Eli Lilly And Company |
Crystalline compositions for controlling blood glucose
|
|
HUP0700126A2
(en)
|
2001-12-20 |
2007-06-28 |
Lilly Co Eli |
Insulin molecule having protracted time action
|
|
EP1525219B1
(en)
|
2002-07-04 |
2009-05-27 |
Zealand Pharma A/S |
Glp-1 and methods for treating diabetes
|
|
MXPA05003335A
(es)
|
2002-10-02 |
2005-07-05 |
Zealand Pharma As |
Compuestos de exendina-4 estabilizados.
|
|
US7192922B2
(en)
|
2002-11-19 |
2007-03-20 |
Allegheny-Singer Research Institute |
Method of treating left ventricular dysfunction
|
|
GB0300571D0
(en)
|
2003-01-10 |
2003-02-12 |
Imp College Innovations Ltd |
Modification of feeding behaviour
|
|
CA2518776A1
(en)
|
2003-04-29 |
2004-11-11 |
Eli Lilly And Company |
Insulin analogs having protracted time action
|
|
WO2004105781A2
(en)
*
|
2003-06-03 |
2004-12-09 |
Novo Nordisk A/S |
Stabilized pharmaceutical peptide compositions
|
|
US7623530B2
(en)
|
2003-11-20 |
2009-11-24 |
Nokia Corporation |
Indication of service flow termination by network control to policy decision function
|
|
RU2006131046A
(ru)
|
2004-01-30 |
2008-03-10 |
Уэрейта Фармасьютикалз, Инк. (Ca) |
Совместное применение агониста glp-1 и соединений гастрина
|
|
US8076288B2
(en)
|
2004-02-11 |
2011-12-13 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides having glucose lowering activity
|
|
CN102772787A
(zh)
|
2004-11-12 |
2012-11-14 |
诺和诺德公司 |
促胰岛素肽的稳定制剂
|
|
TWI362392B
(en)
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
WO2006121860A2
(en)
|
2005-05-06 |
2006-11-16 |
Bayer Pharmaceuticals Corporation |
Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use
|
|
RU2485135C2
(ru)
|
2005-06-13 |
2013-06-20 |
Импиэриэл Инноувейшнс Лимитид |
Соединения оксинтомодулина (варианты), фармацевтическая композиция на их основе, способы лечения и профилактики ожирения и сопутствующих заболеваний (варианты) и лекарственное средство (варианты)
|
|
US20090202497A1
(en)
|
2005-08-23 |
2009-08-13 |
The General Hospital Corporation |
Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes
|
|
CN101534846B
(zh)
*
|
2005-11-07 |
2014-11-05 |
印第安纳大学研究及科技有限公司 |
显示生理学溶解性和稳定性的胰高血糖素类似物
|
|
WO2007081824A2
(en)
|
2006-01-06 |
2007-07-19 |
Case Western Reserve University |
Fibrillation resistant proteins
|
|
WO2007095737A1
(en)
|
2006-02-21 |
2007-08-30 |
Waratah Pharmaceuticals Inc. |
Combination therapy for the treatment of diabetes comprising an exendin agonist and a gastrin compound
|
|
US7928058B2
(en)
|
2006-02-22 |
2011-04-19 |
Merck Sharp & Dohme Corp. |
Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition
|
|
CA2658276A1
(en)
|
2006-07-18 |
2008-01-24 |
Sanofi-Aventis |
Antagonist antibody for the treatment of cancer
|
|
ITMI20061607A1
(it)
|
2006-08-09 |
2008-02-10 |
Maria Vincenza Carriero |
Peptidi con attivita farmacologica
|
|
EP2074140B8
(en)
|
2006-10-04 |
2015-10-28 |
Case Western Reserve University |
Fibrillation-resistant insulin and insulin analogues
|
|
BRPI0718566A2
(pt)
|
2006-11-08 |
2014-03-11 |
Zealand Pharma As |
Peptídeo, análogo do mesmo, composição farmacêutica, usos de um análogo de peptídeo, e de uma molécula de ácido nucléico, de um vetor de expressão, ou de uma célula hospedeira, molécula de ácido nucléico, vetor de expressão, célula hospedeira, métodos para produzir o análogo de peptídeo-2 tipo-glucagon (glp-2), e, kit terapêutico.
|
|
WO2008071010A1
(en)
|
2006-12-12 |
2008-06-19 |
Waratah Pharmaceuticals Inc. |
Combination treatments with selected growth/hormone regulatory factors for diabetes and related diseases
|
|
TWI428346B
(zh)
|
2006-12-13 |
2014-03-01 |
Imp Innovations Ltd |
新穎化合物及其等對進食行為影響
|
|
CN101578102B
(zh)
*
|
2007-01-05 |
2013-07-17 |
印第安纳大学研究及科技有限公司 |
在生理性pH缓冲液中显示增强的溶解性的胰高血糖素类似物
|
|
AU2008216265B2
(en)
|
2007-02-15 |
2014-04-03 |
Indiana University Research And Technology Corporation |
Glucagon/GLP-1 receptor co-agonists
|
|
EP2025684A1
(en)
|
2007-08-15 |
2009-02-18 |
Zealand Pharma A/S |
Glucagon analogues
|
|
US7994122B2
(en)
|
2007-06-15 |
2011-08-09 |
Zealand Pharma A/S |
Glucagon analogues
|
|
FR2917552B1
(fr)
|
2007-06-15 |
2009-08-28 |
Sagem Defense Securite |
Procede de regulation de la gigue de transmission au sein d'un terminal de reception
|
|
US8946148B2
(en)
|
2007-11-20 |
2015-02-03 |
Ambrx, Inc. |
Modified insulin polypeptides and their uses
|
|
GB2455553B
(en)
|
2007-12-14 |
2012-10-24 |
Nuaire Ltd |
Motor mounting assembly for an axial fan
|
|
DE102008003568A1
(de)
|
2008-01-09 |
2009-07-16 |
Sanofi-Aventis Deutschland Gmbh |
Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
|
|
KR20100111683A
(ko)
|
2008-01-09 |
2010-10-15 |
사노피-아벤티스 도이칠란트 게엠베하 |
극히 지연된 시간-작용 프로필을 갖는 신규 인슐린 유도체
|
|
DE102008003566A1
(de)
|
2008-01-09 |
2009-07-16 |
Sanofi-Aventis Deutschland Gmbh |
Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
|
|
KR20100111682A
(ko)
|
2008-01-09 |
2010-10-15 |
사노피-아벤티스 도이칠란트 게엠베하 |
극히 지연된 시간-작용 프로필을 갖는 신규 인슐린 유도체
|
|
WO2009129250A2
(en)
|
2008-04-14 |
2009-10-22 |
Case Western Reserve University |
Meal-time insulin analogues of enhanced stability
|
|
RU2010147076A
(ru)
|
2008-04-22 |
2012-05-27 |
Кейз Вестерн Ризев Юнивесити (Us) |
Аналоги инсулина специфичные к изоформам
|
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
|
CN102088989B
(zh)
*
|
2008-06-17 |
2014-11-26 |
印第安纳大学研究及科技有限公司 |
在生理pH缓冲液中具有增强的溶解性和稳定性的胰高血糖素类似物
|
|
CL2009001425A1
(es)
|
2008-06-17 |
2010-04-30 |
Univ Indiana Res & Tech Corp |
Analogos de glucagon con un aminoacido aromatico grande que carece de cadena lateral de imidazol que le confiere actividad agonista del receptor gip; composiciones farmaceutica; kit que los contiene y uso para reducir el aumento de peso, tratar la diabetes o inducir paralisis del tracto intestinal.
|
|
PA8830501A1
(es)
|
2008-06-17 |
2010-07-27 |
Univ Indiana Res & Tech Corp |
Co-agonistas del receptor de glucagon/glp-1
|
|
PL219335B1
(pl)
|
2008-07-04 |
2015-04-30 |
Inst Biotechnologii I Antybiotyków |
Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, jej zastosowanie oraz zawierająca ją kompozycja farmaceutyczna
|
|
WO2010014946A2
(en)
|
2008-07-31 |
2010-02-04 |
Case Western Reserve University |
Halogen-stabilized insulin
|
|
EP2987805A3
(en)
|
2008-08-07 |
2016-04-13 |
Ipsen Pharma S.A.S. |
Analogues of glucose-dependent insulinotropic polypeptide
|
|
US8637647B2
(en)
|
2008-09-12 |
2014-01-28 |
Novo Nordisk A/S |
Method of acylating a peptide or protein
|
|
UA104605C2
(uk)
*
|
2008-12-15 |
2014-02-25 |
Зіленд Фарма А/С |
Аналоги глюкагону
|
|
CA2747155A1
(en)
|
2008-12-15 |
2010-06-24 |
Zealand Pharma A/S |
Glucagon analogues
|
|
ES2477880T3
(es)
|
2008-12-15 |
2014-07-18 |
Zealand Pharma A/S |
Análogos del glucagón
|
|
CN102292348B
(zh)
|
2008-12-15 |
2015-07-08 |
西兰制药公司 |
胰高血糖素类似物
|
|
CA2747490C
(en)
|
2008-12-19 |
2017-02-14 |
Indiana University Research And Technology Corporation |
Insulin analogs
|
|
WO2010080609A1
(en)
|
2008-12-19 |
2010-07-15 |
Indiana University Research And Technology Corporation |
Amide-based insulin prodrugs
|
|
WO2010096052A1
(en)
|
2009-02-19 |
2010-08-26 |
Merck Sharp & Dohme Corp. |
Oxyntomodulin analogs
|
|
WO2010107487A2
(en)
|
2009-03-18 |
2010-09-23 |
Wu Nian |
Lipid-drug conjugates for drug delivery
|
|
CN101519446A
(zh)
|
2009-03-31 |
2009-09-02 |
上海一就生物医药有限公司 |
一种重组人胰岛素及其类似物的制备方法
|
|
AU2010245739B2
(en)
|
2009-05-08 |
2013-07-11 |
Genentech, Inc. |
Humanized anti-EGFL7 antibodies and methods using same
|
|
MX2011013625A
(es)
|
2009-06-16 |
2012-01-20 |
Univ Indiana Res & Tech Corp |
Compuestos glucagon activo de receptor de gip.
|
|
EA022816B1
(ru)
*
|
2009-07-13 |
2016-03-31 |
Зилэнд Фарма А/С |
Ацилированные аналоги глюкагона
|
|
AU2010338387B2
(en)
|
2009-12-16 |
2014-10-23 |
Novo Nordisk A/S |
Double-acylated GLP-1 derivatives
|
|
WO2011084808A2
(en)
|
2009-12-21 |
2011-07-14 |
Amunix Operating Inc. |
Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases
|
|
CA2786934A1
(en)
|
2010-01-20 |
2011-07-28 |
Zealand Pharma A/S |
Treatment of cardiac conditions
|
|
US8551946B2
(en)
|
2010-01-27 |
2013-10-08 |
Indiana University Research And Technology Corporation |
Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
|
|
BR112012024379A2
(pt)
*
|
2010-03-26 |
2017-01-10 |
Novo Nordisk As |
"peptídeos glucagon, seu uso, bem como composição farmacêutica"
|
|
AR080592A1
(es)
|
2010-03-26 |
2012-04-18 |
Lilly Co Eli |
Peptido con actividad para el gip-r y glp-1-r, formulacion famaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de diabetes mellitus y para inducir la perdida de peso
|
|
JP2013523620A
(ja)
|
2010-03-26 |
2013-06-17 |
ノヴォ ノルディスク アー／エス |
新規のグルカゴンアナログ
|
|
KR20130098873A
(ko)
|
2010-04-27 |
2013-09-05 |
질랜드 파마 에이/에스 |
Glp-1 수용체 작용제 및 가스트린의 펩타이드 접합체 및 그의 용도
|
|
SG185066A1
(en)
|
2010-04-27 |
2012-12-28 |
Zhejiang Beta Pharma Inc |
Glucagon-like peptide-1 analogue and use thereof
|
|
UY33462A
(es)
|
2010-06-23 |
2012-01-31 |
Zealand Pharma As |
Analogos de glucagon
|
|
JP6023048B2
(ja)
|
2010-06-24 |
2016-11-09 |
ジーランド ファーマ アクティーゼルスカブ |
グルカゴン類似体
|
|
WO2011163473A1
(en)
*
|
2010-06-25 |
2011-12-29 |
Indiana University Research And Technology Corporation |
Glucagon analogs exhibiting enhanced solubility and stability in physiological ph buffers
|
|
JP6231386B2
(ja)
|
2010-11-09 |
2017-11-15 |
ノヴォ ノルディスク アー／エス |
リンカーを有する二重アシル化されたｇｌｐ−１誘導体
|
|
PH12013501495A1
(en)
|
2011-01-20 |
2013-09-16 |
Zealand Pharma As |
Combination of acylated glucagon analogues with insulin analogues
|
|
BR112013024076A2
(pt)
|
2011-03-28 |
2016-12-06 |
Novo Nordisk As |
análogos de glucagon
|
|
CN106117343B
(zh)
|
2011-04-12 |
2020-11-03 |
诺沃—诺迪斯克有限公司 |
双酰化glp-1衍生物
|
|
WO2012150503A2
(en)
|
2011-05-03 |
2012-11-08 |
Zealand Pharma A/S |
Glu-glp-1 dual agonist signaling-selective compounds
|
|
WO2012153196A2
(en)
|
2011-05-10 |
2012-11-15 |
Zealand Pharma A/S |
Glu-glp-1 dual agonist signaling-selective compounds
|
|
KR102002783B1
(ko)
|
2011-06-10 |
2019-07-24 |
베이징 한미 파마슈티컬 컴퍼니 리미티드 |
포도당 의존성 인슐리노트로핀 폴리펩타이드 유사물질, 이의 약학적 조성물 및 응용
|
|
CN104093735B
(zh)
*
|
2011-09-23 |
2018-07-06 |
诺沃—诺迪斯克有限公司 |
新的胰高血糖素类似物
|
|
AP2014007797A0
(en)
|
2011-12-23 |
2014-07-31 |
Boehringer Ingelheim Int |
Glucagon analogues
|
|
WO2013098408A1
(en)
*
|
2011-12-30 |
2013-07-04 |
Zealand Pharma A/S |
Glucagon and cck receptor agonist peptide conjugates
|
|
MX356958B
(es)
|
2012-05-03 |
2018-06-20 |
Zealand Pharma As |
Análogos de péptido-2 tipo glucagón (glp-2).
|
|
EA028665B1
(ru)
|
2012-05-03 |
2017-12-29 |
Зилэнд Фарма А/С |
Соединения - двойные агонисты gip-glp-1 и способы
|
|
NZ704043A
(en)
*
|
2012-07-23 |
2017-07-28 |
Zealand Pharma As |
Glucagon analogues
|
|
TWI608013B
(zh)
|
2012-09-17 |
2017-12-11 |
西蘭製藥公司 |
升糖素類似物
|
|
HRP20181505T1
(hr)
|
2013-10-17 |
2018-11-02 |
Zealand Pharma A/S |
Acilirani analozi glukagona
|
|
US9988429B2
(en)
|
2013-10-17 |
2018-06-05 |
Zealand Pharma A/S |
Glucagon analogues
|
|
US10093713B2
(en)
|
2013-11-06 |
2018-10-09 |
Zealand Pharma A/S |
GIP-GLP-1 dual agonist compounds and methods
|
|
MX2016010599A
(es)
|
2014-02-18 |
2016-11-18 |
Novo Nordisk As |
Analogos de glucagon estables y uso para el tratamiento de hipoglucemia.
|
|
KR20170137198A
(ko)
|
2015-04-16 |
2017-12-12 |
질랜드 파마 에이/에스 |
아실화된 글루카곤 유사체
|